← Back to patent-cliff list
Hydrochlorothiazide/Telmisartan
Tier C — Watch / tradeHydrochlorothiazide/Telmisartan
Boehringer Ingelheim
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Thiazide-sensitive sodium-chloride cotransporter, AT1
Brand：Kinzalkomb, Micardis Hct, Micardis plus, PritorPlus, MicardisPlus, Micombi
Indications (approved)：Hypertension
Regional status
US
Approved
2000-11-17
EU
Approved
2002-04-19
China
Approved
2008-04-22
Japan
Approved
2009-04-22
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Hydrochlorothiazide/Telmisartan?
Approved indications include: Hypertension.
When does the Hydrochlorothiazide/Telmisartan patent expire?
No public expiry year is available for Hydrochlorothiazide/Telmisartan yet; this page updates once verified.
How do I get a quote for Hydrochlorothiazide/Telmisartan intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04